The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...

In January, 2025, six wildfires broke out and spread rapidly across the greater Los Angeles region in California, USA. Fanned by the strong Santa Ana winds, these raging infernos have caused ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

Exposure to adverse childhood experiences (ACEs), including abuse, neglect, and household challenges, have harmful implications for long-term health and mental health outcomes.1 Indeed, ACEs are one ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

Believers in haematological destiny would be intrigued to know that Cristóbal Frutos was born on May 28, which is World Blood Cancer Day. Still a few years younger than 40 years, he is the transplant ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

The International Agency for Research on Cancer predicts more than 35 million new cancer cases in 2050, a 77% increase from 2022. The greatest burden will fall on low-income and middle-income ...